Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085709
Status:
COMPLETED
Last Update Posted:
2015-09-30
First Post:
2004-06-14
Brief Title:
S0106 Cytarabine and Daunorubicin w or wo Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| untreated adult acute myeloid leukemia | View |
| adult acute eosinophilic leukemia | View |
| adult acute basophilic leukemia | View |
| adult acute monocytic leukemia M5b | View |
| adult acute erythroid leukemia M6 | View |
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute minimally differentiated myeloid leukemia M0 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute monoblastic leukemia M5a | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with t821q22q22 | View |